Avaleht › Crohni tõbi › Rhode Island
Crohni tõbi kliinilised uuringud osariigis Rhode Island
12 uuringut haiguse Crohni tõbi jaoks otsivad osalejaid osariigis Rhode Island.
Linnad osariigis Rhode Island
Ametlik uuringutekst (inglise keeles)
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
- University Gastroenterology - Providence - West River Street ( Site 5057), Providence
VärbamineFaas 3
Vanused 16–80 · Kõik sood · Uuendatud 2. okt 2026 · NCT06430801Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
- University Gastroenterology - Providence - Staniford Street /ID# 280919, Providence
VärbamineFaas 2
Vanused 18–75 · Kõik sood · Uuendatud 2. okt 2026 · NCT07697456A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
- University Gastroenterology, Providence
VärbamineFaas 4
Vanused 18–80 · Kõik sood · Uuendatud 30. sept 2026 · NCT06581328A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
- University Gastroenterology, Providence
VärbamineFaas 2/3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 25. sept 2026 · NCT07196722A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
- University Gastroenterology Providence, Providence
VärbamineFaas 2
Vanused 18–75 · Kõik sood · Uuendatud 25. sept 2026 · NCT06233461Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
- University Gastroenterology, Providence
VärbamineFaas 3
Vanused 18–70 · Kõik sood · Uuendatud 24. sept 2026 · NCT06937099An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
- University Gastroenterology-Site Number: 8400103, Providence
VärbamineFaas 3
Vanused 16–80 · Kõik sood · Uuendatud 23. sept 2026 · NCT07184931A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
- University Gastroenterology - GI Alliance-Site Number: 8400103, Providence
VärbamineFaas 3
Vanused 16–80 · Kõik sood · Uuendatud 23. sept 2026 · NCT07184944A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
- University Gastroenterology, Providence
VärbamineFaas 4
Vanused 18–70 · Kõik sood · Uuendatud 9. sept 2026 · NCT06045754Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
- Gastroenterology Associates, Providence
Värbamine
Vanused 18 ja vanemad · Kõik sood · Uuendatud 7. aug 2026 · NCT05230173Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease
- Rhode Island Hospital, Providence
VärbamineFaas 4
Vanused 6–17 · Kõik sood · Uuendatud 27. mai 2026 · NCT05781152A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
- Mirador Therapeutics Selected Site, Providence
VärbamineFaas 2
Vanused 18–80 · Kõik sood · Uuendatud 12. märts 2026 · NCT07113522Allikas ClinicalTrials.gov, andmed saadud 5. okt 2026. Igal uuringul on oma osalemiskõlblikkuse tingimused; uuringumeeskond otsustab, kes saab osaleda.